KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Assets (2019 - 2026)

GoodRx Holdings' Assets history spans 7 years, with the latest figure at $1.4 billion for Q4 2025.

  • On a quarterly basis, Assets rose 1.15% to $1.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 billion, a 1.15% increase, with the full-year FY2025 number at $1.4 billion, up 1.15% from a year prior.
  • Assets hit $1.4 billion in Q4 2025 for GoodRx Holdings, up from $1.3 billion in the prior quarter.
  • Over the last five years, Assets for GDRX hit a ceiling of $1.7 billion in Q3 2023 and a floor of $1.3 billion in Q1 2025.
  • Historically, Assets has averaged $1.5 billion across 5 years, with a median of $1.6 billion in 2022.
  • Biggest five-year swings in Assets: grew 9.35% in 2021 and later decreased 20.68% in 2024.
  • Tracing GDRX's Assets over 5 years: stood at $1.6 billion in 2021, then fell by 0.19% to $1.6 billion in 2022, then decreased by 0.99% to $1.6 billion in 2023, then decreased by 12.63% to $1.4 billion in 2024, then grew by 1.15% to $1.4 billion in 2025.
  • Business Quant data shows Assets for GDRX at $1.4 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.3 billion in Q2 2025.